Cases of sexually transmitted diseases in San Francisco dramatically dropped in 2025 when compared to previous years, as ...

Gonorrhea is a common sexually transmitted disease (STD) that causes infection in more than 1.5 million people every year in the United States. The infection is caused by Neisseria gonorrhoeae, a type ...

1. Nuzolvence (zoliflodacin) is the first single‑dose oral agent for uncomplicated urogenital gonorrhea, showing non‑inferior cure rates to ceftriaxone‑based therapy with mainly mild GI adverse events ...

Nuzolvence oral granules need to be mixed with water and administered within 15 minutes of mixing. The Food and Drug Administration (FDA) has approved Nuzolvence ® (zoliflodacin for oral suspension) ...

FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against Neisseria gonorrhoeae infection in regions with a high prevalence of gonorrhea ...

For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...

The FDA has approved Nuzolvence as a new single-dose oral option for uncomplicated urogenital gonorrhea in adults and children 12 years and older who weigh at least 77 pounds. The FDA approved ...